RP
Therapeutic Areas
Bristol Myers Squibb Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Opdivo (nivolumab) | Multiple cancer types | Commercial |
| Yervoy (ipilimumab) | Melanoma and other cancers | Commercial |
| Revlimid (lenalidomide) | Multiple myeloma | Commercial |
| Eliquis (apixaban) | Atrial fibrillation | Commercial |
| Sprycel (dasatinib) | CML, ALL | Commercial |
| Breyanzi (lisocabtagene) | B-cell lymphomas | Commercial |
| Abecma (idecabtagene) | Multiple myeloma | Commercial |
| Camzyos (mavacamten) | Hypertrophic cardiomyopathy | Commercial |